NCT05970302
- Conditions
- Bevacizumab, Capecitabine, Colonic Diseases, +16 more
- Locations
-
- Lin Yang Beijing, China
Clinical trial condition
RAS-mutated
Explore clinical trials studying RAS-mutated. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study